{"DataElement":{"publicId":"3005338","version":"1","preferredName":"Skin Graft Versus Host Disease Pain Assessment Score","preferredDefinition":"Numeric value that is a subject assessment of pain due to skin disease caused by Graft versus Host Disease (GVHD). This is part of the chronic GVHD Composite Assessment Scale evaluation tool, but does not contribute to that score.","longName":"SKN_GVHD_PN_ASSM_SC","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3005334","version":"1","preferredName":"Skin Graft Versus Host Disease Pain Assessment","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part._An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.__The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings._The final result of a determination of the value, significance, or extent of.","longName":"SKN_GVHD_PN_ASSM","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"3005319","version":"1","preferredName":"Skin Graft Versus Host Disease","preferredDefinition":"1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part.:An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","longName":"C12470:C3063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CE16-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-02","modifiedBy":"ONEDATA","dateModified":"2010-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3005332","version":"1","preferredName":"Pain Assessment","preferredDefinition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.:The final result of a determination of the value, significance, or extent of.","longName":"C3303:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF51-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF62-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3005336","version":"1","preferredName":"Scale Chronic Graft versus Host Disease Score","preferredDefinition":"A syndrome of immologically mediated tissue damage occurring following allogeneic transplant and may affect multiple organs with manifestations similar to autoimmune diseases.  Onset is usually within three years of transplantation or immunologic manipulation.","longName":"SCL_CGVHD_SC","context":"CCR","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"1","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3005339","version":"1","preferredName":"Scale Chronic Graft Versus Host Disease Score","preferredDefinition":"an ordered reference standard.:A syndrome of immologically mediated tissue damage occurring following allogeneic transplant and may affect multiple organs with manifestations similar to autoimmune diseases.  Onset is usually within three years of transplantation or immunologic manipulation.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25664:C4981:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CFC3-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"ONEDATA","dateModified":"2010-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF89-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"REEVESD","dateModified":"2010-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Pain","type":"Preferred Question Text","description":"Pain","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EAB8C7C-CF9D-328C-E040-BB89AD433B37","latestVersionIndicator":"Yes","beginDate":"2010-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-02-03","modifiedBy":"PRICEA","dateModified":"2013-10-23","changeDescription":"Curated to support CCR Transplantation trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}